Asia Pacific Small Molecule API Market Outlook, 2029
The Asia Pacific Small Molecule API Market is projected to reach a staggering USD 320 billion by 2027, driven by rise in cost effectiveness.
- Bonafide Trust
- 30-11-2023
- Pages : 131
- Figures : 51
- Tables : 67
- Region : Asia-Pacific
- Category : Lifescience
- Pharmaceutical
According to publisher, The Asia-Pacific (APAC) small molecule Active Pharmaceutical Ingredient (API) market is experiencing phenomenal growth, driven by a confluence of factors.
Market Insights:
Market Size and Growth: The APAC small molecule API market is projected to reach a staggering USD 320 billion by 2027, with a robust CAGR exceeding 8%. This growth signifies the region's increasing importance in global pharmaceutical manufacturing.
What's Inside a Bonafide Research`s industry report?
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Download SampleGrowth Drivers: Several factors are propelling the APAC small molecule API market forward:
Aging Population: The rapidly aging population in APAC countries like China and India creates a surge in demand for affordable generic drugs, with small molecule APIs being the backbone of these medications.
Cost-Effectiveness: Small molecule APIs offer a cost-effective alternative to complex biologics, making them suitable for developing economies within the region.
Government Support: Governments in APAC countries are actively promoting domestic API production through subsidies and infrastructure development initiatives.
Example: The Indian government launched the "Bulk Drugs Promotion Policy" to incentivize local API manufacturing, aiming to reduce dependence on imports.
Benefits of a Thriving APAC API Market:
Enhanced Drug Accessibility: Increased domestic API production improves access to affordable medications for patients across the region.
Strengthened Supply Chains: A robust local API industry reduces reliance on imports and mitigates potential supply chain disruptions.
Boosted Innovation: The growing API market fosters innovation in drug discovery and development within the region.
Market Dynamics:
The APAC small molecule API market is a dynamic environment shaped by several key forces:
Stringent Regulatory Landscape: Regulatory bodies like China's National Medical Products Administration (NMPA) are implementing stricter quality control measures, impacting API manufacturers and requiring adherence to international standards.
Environmental Concerns: Environmental regulations regarding wastewater treatment and waste disposal are becoming more stringent, prompting API manufacturers to adopt sustainable practices.
Intellectual Property (IP) Challenges: Concerns regarding intellectual property infringement can hinder innovation and technology transfer within the region.
Market Segments:
The APAC small molecule API market can be segmented based on:
Therapeutic Area:
Cardiovascular drugs
Anti-infectives
Oncology drugs
Central nervous system (CNS) drugs
API Type:
Generic APIs
Branded APIs
Regional Analysis:
The APAC small molecule API market exhibits variations across the region:
China: China is the dominant player in the APAC API market, with a large manufacturing base and government support for domestic production.
India: India is a major player known for its cost-competitive API production, particularly for generic drugs.
Other Emerging Markets: Countries like South Korea and Singapore are also witnessing growth in their API sectors, focusing on high-value APIs and advanced manufacturing technologies.
Key Developments:
Focus on Quality and Compliance: Leading API manufacturers are investing in quality control measures and international certifications to comply with stringent regulations.
Contract Manufacturing: Contract manufacturing arrangements are becoming increasingly popular, allowing pharmaceutical companies to outsource API production to cost-effective manufacturers in the region.
Technological Advancements: The adoption of advanced technologies like continuous manufacturing and automation is improving efficiency and production capacity within the APAC API sector.
Competitive Landscape:
The APAC small molecule API market is a competitive landscape with a mix of:
Established Domestic Players: Leading domestic API manufacturers in China and India hold a significant market share.
Multinational Pharmaceutical Companies: Multinational pharmaceutical companies are setting up API manufacturing facilities within the region to capitalize on cost advantages.
Contract Manufacturing Organizations (CMOs): CMOs are playing an increasingly important role, offering a flexible and cost-effective solution for API production.
The burgeoning APAC small molecule API market presents exciting opportunities for pharmaceutical companies and manufacturers. By embracing innovation, maintaining quality standards, and navigating the dynamic regulatory landscape, the APAC region can solidify its position as a global leader in API production.
Table of Contents
- 1 Introduction 8
- 1.1 Industry Definition and Research Scope 8
- 1.1.1 Industry Definition 8
- 1.1.2 Research Scope 9
- 1.2 Research Methodology 12
- 1.2.1 Overview of Market Research Methodology 12
- 1.2.2 Market Assumption 13
- 1.2.3 Secondary Data 13
- 1.2.4 Primary Data 13
- 1.2.5 Data Filtration and Model Design 14
- 1.2.6 Market Size/Share Estimation 15
- 1.2.7 Research Limitations 16
- 1.3 Executive Summary 17
- 2 Market Overview and Dynamics 20
- 2.1 Market Size and Forecast 20
- 2.1.1 Impact of COVID-19 on World Economy 21
- 2.1.2 Impact of COVID-19 on the Market 24
- 2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery 26
- 2.2 Major Growth Drivers 30
- 2.3 Market Restraints and Challenges 34
- 2.4 Emerging Opportunities and Market Trends 37
- 2.5 Porter’s Fiver Forces Analysis 41
- 3 Segmentation of Asia Pacific Market by Source 45
- 3.1 Market Overview by Source 45
- 3.2 Synthetic API 47
- 3.2.1 Branded Synthetic API 48
- 3.2.2 Generic Synthetic API 49
- 3.3 Semi-synthetic API 50
- 3.4 Natural Origin 51
- 4 Segmentation of Asia Pacific Market by Product Type 52
- 4.1 Market Overview by Product Type 52
- 4.2 Standard API 54
- 4.3 High Potency API (HPAPI) 55
- 4.3.1 Branded HPAPI 56
- 4.3.2 Generic HPAPI 57
- 5 Segmentation of Asia Pacific Market by Therapeutic Area 58
- 5.1 Market Overview by Therapeutic Area 58
- 5.2 Infectious Diseases 60
- 5.3 Oncology 61
- 5.4 Ophthalmology 62
- 5.5 Cardiovascular Disorders 63
- 5.6 Central Nervous System 64
- 5.7 Respiratory Disorders 65
- 5.8 Metabolic Diseases 66
- 5.9 Other Therapeutic Areas 67
- 6 Segmentation of Asia Pacific Market by Application 68
- 6.1 Market Overview by Application 68
- 6.2 Clinical Use 70
- 6.3 Commercial Use 71
- 7 Segmentation of Asia Pacific Market by Manufacturer Type 72
- 7.1 Market Overview by Manufacturer Type 72
- 7.2 Pharmaceutical Companies 74
- 7.3 CMOs 76
- 8 Asia-Pacific Market 2022-2032 by Country 78
- 8.1 Overview of Asia-Pacific Market 78
- 8.2 Japan 81
- 8.3 China 84
- 8.4 Australia 86
- 8.5 India 88
- 8.6 South Korea 90
- 8.7 Rest of APAC Region 92
- 9 Competitive Landscape 94
- 9.1 Overview of Key Vendors 94
- 9.2 New Product Launch, Partnership, Investment, and M&A 97
- 9.3 Company Profiles 98
- Aurobindo Pharma Ltd. 98
- Cambrex Corporation 100
- Catalent Inc. 101
- Dr. Reddy's Laboratories 104
- GlaxoSmithKline plc 107
- Lonza Group 111
- Merck & Co., Inc. 114
- Mylan N.V. 116
- Novartis AG 118
- Pfizer Inc. 120
- Sun Pharmaceutical Industries Ltd. 124
- Teva Pharmaceutical Industries Ltd. 127
- Wuxi AppTec Co., Ltd. 129
- RELATED REPORTS 131
Table 1. Snapshot of Asia Pacific Small Molecule API Market in Balanced Perspective, 2022-2032 18
Table 2. World Economic Outlook, 2021-2031 22
Table 3. World Economic Outlook, 2021-2023 23
Table 4. Scenarios for Economic Impact of Ukraine Crisis 27
Table 5. World Health Spending by Region, $ bn, 2013-2020 32
Table 6. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn 33
Table 7. Main Product Trends and Market Opportunities in Asia Pacific Small Molecule API Market 37
Table 8. Asia Pacific Small Molecule API Market by Source, 2022-2032, $ mn 45
Table 9. Asia Pacific Small Molecule API Market: Synthetic API by Drug Type, 2022-2032, $ mn 47
Table 10. Asia Pacific Small Molecule API Market by Product Type, 2022-2032, $ mn 52
Table 11. Asia Pacific Small Molecule API Market: HPAPI by Drug Type, 2022-2032, $ mn 55
Table 12. Asia Pacific Small Molecule API Market by Therapeutic Area, 2022-2032, $ mn 58
Table 13. Asia Pacific Small Molecule API Market by Application, 2022-2032, $ mn 68
Table 14. Asia Pacific Small Molecule API Market by Manufacturer Type, 2022-2032, $ mn 72
Table 15. APAC Small Molecule API Market by Country, 2022-2032, $ mn 79
Table 16. Japan Small Molecule API Market by Product Type, 2022-2032, $ mn 83
Table 17. Japan Small Molecule API Market by Therapeutic Area, 2022-2032, $ mn 83
Table 18. Japan Small Molecule API Market by Manufacturer Type, 2022-2032, $ mn 83
Table 19. China Small Molecule API Market by Product Type, 2022-2032, $ mn 85
Table 20. China Small Molecule API Market by Therapeutic Area, 2022-2032, $ mn 85
Table 21. China Small Molecule API Market by Manufacturer Type, 2022-2032, $ mn 85
Table 22. Australia Small Molecule API Market by Product Type, 2022-2032, $ mn 87
Table 23. Australia Small Molecule API Market by Therapeutic Area, 2022-2032, $ mn 87
Table 24. Australia Small Molecule API Market by Manufacturer Type, 2022-2032, $ mn 87
Table 25. India Small Molecule API Market by Product Type, 2022-2032, $ mn 89
Table 26. India Small Molecule API Market by Therapeutic Area, 2022-2032, $ mn 89
Table 27. India Small Molecule API Market by Manufacturer Type, 2022-2032, $ mn 89
Table 28. South Korea Small Molecule API Market by Product Type, 2022-2032, $ mn 91
Table 29. South Korea Small Molecule API Market by Therapeutic Area, 2022-2032, $ mn 91
Table 30. South Korea Small Molecule API Market by Manufacturer Type, 2022-2032, $ mn 91
Table 31. Small Molecule API Market in Rest of APAC by Country/Region, 2022-2032, $ mn 93
Table 32. Aurobindo Pharma Ltd.: Company Snapshot 98
Table 33. Aurobindo Pharma Ltd.: Business Segmentation 99
Table 34. Aurobindo Pharma Ltd.: Product Portfolio 99
Table 35. Cambrex Corporation: Company Snapshot 100
Table 36. Catalent Inc.: Company Snapshot 101
Table 37. Catalent Inc.: Business Segmentation in 2018 101
Table 38. Catalent Inc.: Product Portfolio 102
Table 39. Catalent Inc.: Revenue, 2018-2020, $ million 102
Table 40. Catalent Inc.: Revenue by Region in 2018 103
Table 41. Dr. Reddy's Laboratories: Company Snapshot 104
Table 42. Dr. Reddy's Laboratories: Business Segmentation 104
Table 43. Dr. Reddy's Laboratories: Revenue, 2018-2020, $ bn 105
Table 44. GlaxoSmithKline: Company Snapshot 107
Table 45. GlaxoSmithKline: Business Segmentation 108
Table 46. GlaxoSmithKline: Product Portfolio 109
Table 47. GlaxoSmithKline: Revenue, 2018-2020, $ bn 110
Table 48. Lonza Group: Company Snapshot 111
Table 49. Lonza Group: Business Segmentation in 2018 111
Table 50. Lonza Group: Product Portfolio 112
Table 51. Lonza Group: Revenue by Region in 2018 112
Table 52. Merck & Co., Inc.: Company Snapshot 114
Table 53. Merck & Co., Inc.: Business Segmentation 114
Table 54. Merck & Co., Inc.: Revenue, 2018-2020, $ bn 115
Table 55. Mylan NV: Company Snapshot 116
Table 56. Mylan NV: Revenue, 2017-2019, $ bn 117
Table 57. Novartis International AG: Company Snapshot 118
Table 58. Novartis International AG: Business Segmentation 118
Table 59. Novartis International AG: Revenue, 2017-2019, $ bn 119
Table 60. Pfizer Inc.: Company Snapshot 120
Table 61. Pfizer Inc.: Business Segmentation 121
Table 62. Pfizer Inc.: Product Portfolio 122
Table 63. Pfizer Inc.: Revenue, 2018-2020, $ bn 122
Table 64. Sun Pharmaceutical Industries Limited: Company Snapshot 124
Table 65. Teva Pharmaceutical Industries Ltd.: Company Snapshot 127
Table 66. Teva Pharmaceutical Industries Ltd.: Business Segmentation 128
Table 67. WuXi AppTec Inc.: Company Snapshot 129
Figure 1. Research Method Flow Chart 12
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2032 17
Figure 4. Asia Pacific Small Molecule API Market, 2022-2032, $ mn 20
Figure 5. Impact of COVID-19 on Business 24
Figure 6. Primary Drivers and Impact Factors of Asia Pacific Small Molecule API Market 30
Figure 7. Primary Restraints and Impact Factors of Asia Pacific Small Molecule API Market 34
Figure 8. Investment Opportunity Analysis 38
Figure 9. Porter’s Fiver Forces Analysis of Asia Pacific Small Molecule API Market 41
Figure 10. Breakdown of Asia Pacific Small Molecule API Market by Source, 2022-2032, % of Revenue 46
Figure 11. Asia Pacific Addressable Market Cap in 2023-2032 by Source, Value ($ mn) and Share (%) 46
Figure 12. Asia Pacific Small Molecule API Market by Source: Synthetic API, 2022-2032, $ mn 47
Figure 13. Asia Pacific Small Molecule API Market by Synthetic API: Branded Synthetic API, 2022-2032, $ mn 48
Figure 14. Asia Pacific Small Molecule API Market by Synthetic API: Generic Synthetic API, 2022-2032, $ mn 49
Figure 15. Asia Pacific Small Molecule API Market by Source: Semi-synthetic API, 2022-2032, $ mn 50
Figure 16. Asia Pacific Small Molecule API Market by Source: Natural Origin, 2022-2032, $ mn 51
Figure 17. Breakdown of Asia Pacific Small Molecule API Market by Product Type, 2022-2032, % of Sales Revenue 53
Figure 18. Asia Pacific Addressable Market Cap in 2023-2032 by Product Type, Value ($ mn) and Share (%) 53
Figure 19. Asia Pacific Small Molecule API Market by Product Type: Standard API, 2022-2032, $ mn 54
Figure 20. Asia Pacific Small Molecule API Market by Product Type: High Potency API (HPAPI), 2022-2032, $ mn 55
Figure 21. Asia Pacific Small Molecule API Market by HPAPI: Branded HPAPI, 2022-2032, $ mn 56
Figure 22. Asia Pacific Small Molecule API Market by HPAPI: Generic HPAPI, 2022-2032, $ mn 57
Figure 23. Breakdown of Asia Pacific Small Molecule API Market by Therapeutic Area, 2022-2032, % of Sales Revenue 59
Figure 24. Asia Pacific Addressable Market Cap in 2023-2032 by Therapeutic Area, Value ($ mn) and Share (%) 59
Figure 25. Asia Pacific Small Molecule API Market by Therapeutic Area: Infectious Diseases, 2022-2032, $ mn 60
Figure 26. Asia Pacific Small Molecule API Market by Therapeutic Area: Oncology, 2022-2032, $ mn 61
Figure 27. Asia Pacific Small Molecule API Market by Therapeutic Area: Ophthalmology, 2022-2032, $ mn 62
Figure 28. Asia Pacific Small Molecule API Market by Therapeutic Area: Cardiovascular Disorders, 2022-2032, $ mn 63
Figure 29. Asia Pacific Small Molecule API Market by Therapeutic Area: Central Nervous System, 2022-2032, $ mn 64
Figure 30. Asia Pacific Small Molecule API Market by Therapeutic Area: Respiratory Disorders, 2022-2032, $ mn 65
Figure 31. Asia Pacific Small Molecule API Market by Therapeutic Area: Metabolic Diseases, 2022-2032, $ mn 66
Figure 32. Asia Pacific Small Molecule API Market by Therapeutic Area: Other Therapeutic Areas, 2022-2032, $ mn 67
Figure 33. Breakdown of Asia Pacific Small Molecule API Market by Application, 2022-2032, % of Revenue 69
Figure 34. Asia Pacific Addressable Market Cap in 2023-2032 by Application, Value ($ mn) and Share (%) 69
Figure 35. Asia Pacific Small Molecule API Market by Application: Clinical Use, 2022-2032, $ mn 70
Figure 36. Asia Pacific Small Molecule API Market by Application: Commercial Use, 2022-2032, $ mn 71
Figure 37. Breakdown of Asia Pacific Small Molecule API Market by Manufacturer Type, 2022-2032, % of Revenue 73
Figure 38. Asia Pacific Addressable Market Cap in 2023-2032 by Manufacturer Type, Value ($ mn) and Share (%) 73
Figure 39. Asia Pacific Small Molecule API Market by Manufacturer Type: Pharmaceutical Companies, 2022-2032, $ mn 74
Figure 40. Breakdown of Asia Pacific Small Molecule API In-house Synthesis Market by Region, 2020-2027, % of Revenue 75
Figure 41. Asia Pacific Small Molecule API Market by Manufacturer Type: CMOs, 2022-2032, $ mn 76
Figure 42. Breakdown of Asia Pacific Small Molecule API Contract Synthesis Market by Region, 2020-2027, % of Revenue 77
Figure 43. Breakdown of APAC Small Molecule API Market by Country, 2022 and 2032, % of Revenue 79
Figure 44. Contribution to APAC 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%) 80
Figure 45. Small Molecule API Market in Japan, 2022-2032, $ mn 82
Figure 46. Small Molecule API Market in China, 2022-2032, $ mn 84
Figure 47. Small Molecule API Market in Australia, 2022-2032, $ mn 86
Figure 48. Small Molecule API Market in India, 2022-2032, $ mn 88
Figure 49. Small Molecule API Market in South Korea, 2022-2032, $ mn 90
Figure 50. Small Molecule API Market in Rest of APAC, 2022-2032, $ mn 92
Figure 51. Growth Stage of Asia Pacific Small Molecule API Industry over the Forecast Period 94
Related Reports
One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. Read More
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. Read More
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. Read More
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). Read More
Safe and Secure SSL Encrypted
Quick Contacts
Want to customize this report?
We offer 10% Free Customization at the time of purchase
Get Free Customization.png "Nikita Jabrela")
Trusted Partners
Budget constraints? Get in touch with us for special pricing
Request DiscountOrder Detail
- Order Placed (21 March, 2025)
- Notify To Team (21 March, 2025)
- Report updation (22 March, 2025)
- Report Quality Check (22 March, 2025)
- Report Dispatch (23 March, 2025)
- Hard Copy
Recently Viewed Products
Asia Pacific Small Molecule API Market Outlook, 2029
We are friendly and approachable, give us a call.